Few Young Males Receive HIV Testing at Physician Office Visits

Share this content:
Few Young Males Receive HIV Testing at Physician Office Visits
Few Young Males Receive HIV Testing at Physician Office Visits

TUESDAY, June 28, 2016 (HealthDay News) -- Few young males receive HIV testing during visits to physicians' offices, although the rates are higher for black and Hispanic males than for white males, according to a report published in the June 24 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that in 2014, 81 percent of new HIV infection diagnoses in the United States were in males, with the highest number in those aged 20 to 29 years, D. Cal Ham, M.D., from the CDC in Atlanta, and colleagues identified opportunities for HIV diagnosis in young males.

The researchers found that white males visited physicians' offices more often than black and Hispanic males during 2009 to 2012 (average annual rates of 1.6, 0.9, and 0.8 visits/person, respectively). An HIV test was performed at 1.0 percent of visits made by young males, with higher testing rates seen for black and Hispanic versus white males (2.7 and 1.4 percent, respectively, versus 0.7 percent).

"Although higher proportions of black and Hispanic males received HIV testing at health care visits compared with white males, this benefit is likely attenuated by a lower rate of health care visits," the authors write. "Interventions to routinize HIV testing at U.S. physicians' offices could be implemented to improve HIV testing coverage."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »